Tesamorelin: The FDA-Approved Peptide for Visceral Fat Loss and Body Composition
GLP-1 & Weight Loss Peptides & Hormones

Tesamorelin: The FDA-Approved Peptide for Visceral Fat Loss and Body Composition

12 min read

Key Takeaways

  • Tesamorelin is the only GHRH analog with full FDA approval for a body composition indication, originally approved for HIV-associated lipodystrophy.
  • It preferentially targets visceral fat — the metabolically dangerous fat around internal organs — through GH-mediated lipolysis.
  • Standard dosage is 1-2 mg daily via subcutaneous injection, ideally in the evening to align with natural circadian GH pulses.
  • Stacking tesamorelin with ipamorelin creates synergistic GH release by hitting both the GHRH and ghrelin pathways simultaneously.
  • Cycling 8-12 weeks on and 4 weeks off prevents pituitary desensitization and maintains natural GH pulsatility.
  • Side effects are generally mild at clinical doses — injection site reactions, transient water retention, and joint stiffness are most common.
  • Injectable tesamorelin remains the gold standard over oral or tablet formulations due to superior bioavailability.

Most fat-loss compounds overpromise. Tesamorelin has FDA approval, controlled trial data, and a specific target: visceral fat, the metabolically dangerous kind packed around your organs. Developed for HIV-associated lipodystrophy, this growth hormone-releasing hormone (GHRH) analog has drawn interest from bodybuilders, anti-aging clinicians, and anyone fighting stubborn midsection fat that won’t respond to dialed-in diet and training.

What Is Tesamorelin and How Does It Work?

Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a 44-amino acid peptide that signals your pituitary gland to produce and release more growth hormone (GH) naturally [1][2]. Exogenous GH injections flood your system with a fixed dose. Tesamorelin works with your body’s feedback loops, stimulating endogenous GH production so the pituitary still regulates output rather than being bypassed entirely [12].

That distinction matters more than it sounds. GHRH analogs like tesamorelin up-regulate GH receptors and stimulate natural IGF-1 release without suppressing your own production the way exogenous GH can [12]. The result is a more physiological GH pulse pattern, closer to what a healthy 25-year-old produces than what you get from injecting synthetic somatropin.

Tesamorelin belongs to the same peptide family as sermorelin and CJC-1295, but holds one critical advantage: it is the only GHRH analog with full FDA approval for a body composition indication [1][2][8]. Sold under the brand name Egrifta, it was approved to reduce excess abdominal fat in HIV-positive patients with lipodystrophy, a condition where antiretroviral drugs cause abnormal fat accumulation around the trunk.

Peptides Tesamorelin: Where It Fits in the GH-Releasing Family

The growth hormone secretagogue landscape splits into two camps: GHRH analogs (tesamorelin, sermorelin, CJC-1295) and ghrelin mimetics (ipamorelin, GHRP-2, GHRP-6, MK-677) [13]. GHRH analogs tell the pituitary how much GH to make. Ghrelin mimetics tell it when to release it. Stack one from each category and you get a synergistic pulse neither achieves alone [3][4].

What separates tesamorelin from other GHRH analogs comes down to potency and clinical validation. Sermorelin is older and weaker. CJC-1295 with DAC has a longer half-life but far less human data. Tesamorelin produced measurable visceral fat reduction in controlled trials, with enough safety data that physicians prescribe it confidently [8].

Benefits of Tesamorelin

The benefits of tesamorelin reach beyond its FDA-approved indication. Visceral fat reduction is the headline, but optimized GH levels ripple across multiple systems.

Visceral fat reduction. This is the primary, clinically validated benefit. Tesamorelin reduces visceral adipose tissue, the metabolically active fat surrounding your liver, intestines, and other abdominal organs [1][22]. Visceral fat actively drives insulin resistance, systemic inflammation, and cardiovascular risk [40]. It is not just a cosmetic problem.

Liver fat reduction. Tesamorelin reduces hepatic fat accumulation alongside visceral fat, with implications for non-alcoholic fatty liver disease [22].

Improved body composition. By stimulating natural GH production, tesamorelin promotes lean tissue preservation while mobilizing fat stores. GLP-1 drugs cause significant muscle loss, up to 40% of total weight lost in some trials [35]. Tesamorelin shifts the ratio in favor of fat loss while protecting muscle mass.

Better sleep quality. Growth hormone releases in pulses during deep sleep. Optimizing GH through peptides like tesamorelin can improve sleep architecture, particularly deep-wave sleep stages [6][59]. Steve from Vigorous Steve includes 2–3 IU of tesamorelin pre-bed specifically for sleep and recovery [59].

Metabolic improvements. Higher GH levels improve insulin sensitivity, enhance mitochondrial function, and support muscle protein synthesis [14]. The IGF-1 sweet spot of 100–250 ng/mL, achievable with proper tesamorelin dosing, tracks with optimal metabolic health [8].

Recovery and muscle fullness. Combined with adequate caloric intake, tesamorelin increases intracellular water retention in muscle tissue, amplifying strength and fullness [4]. Athletes using it alongside resistance training notice this most.

Tesamorelin for Visceral Fat and Belly Fat

If belly fat is your primary target, you need to understand the difference between subcutaneous and visceral fat. Subcutaneous fat sits under your skin. Pinchable. Visceral fat wraps around your internal organs and is far more metabolically dangerous. You can have a relatively flat stomach and still carry dangerous visceral deposits. You can also have visible subcutaneous fat that is mostly harmless from a health perspective.

Tesamorelin for visceral fat is one of the few pharmacological interventions with strong human evidence for this specific fat depot [22]. It does not cause generalized weight loss. It preferentially targets the visceral compartment. That specificity is rare. Most fat-loss drugs, including the popular GLP-1 agonists, show modest visceral fat reduction at best. Semaglutide trials showed only 0.44 pounds of visceral fat loss over 52 weeks [35], a number that reveals how stubborn this fat depot really is.

The mechanism: growth hormone activates hormone-sensitive lipase in adipose tissue, and visceral fat cells carry a higher density of GH receptors than subcutaneous fat cells. Visceral triglycerides get mobilized first [22][5].

For tesamorelin for belly fat reduction specifically, the compound works best alongside the fundamentals: resistance training, adequate protein, managed sleep, and a modest caloric deficit. Peptides amplify good habits. They cannot compensate for poor ones [7]. Skip any of those foundations and tesamorelin won’t produce meaningful results.

Tesamorelin Dosage Per Day

The standard medical tesamorelin dosage per day is 2 mg, administered as a single subcutaneous injection [8][23]. This is the dose from the clinical trials that secured FDA approval and the dose on the Egrifta label for HIV-associated lipodystrophy.

For anti-aging and body composition purposes, many clinicians prescribe 1–2 mg daily. Some protocols drop to 1 mg per day, particularly when stacking tesamorelin with other peptides like ipamorelin [8]. The reasoning: lower individual doses reduce side effects while the synergistic effect of multiple peptides maintains or exceeds the GH output of higher single-peptide doses [8].

Timing matters. Tesamorelin is most commonly injected in the evening before bed to align with the body’s natural circadian GH pulse [6][15]. GH release peaks during the first few hours of deep sleep. An evening injection amplifies this natural rhythm rather than creating an unphysiological daytime spike.

Some practitioners favor a split approach: morning ipamorelin plus evening tesamorelin [4][6]. Two distinct GH pulses per day. One supports daytime recovery and performance. The other maximizes nocturnal repair.

Tesamorelin Ipamorelin Dosage Per Day

The tesamorelin ipamorelin combination is the most widely discussed peptide stack in the GH-releasing category. A typical daily protocol:

  • Morning: 100–300 mcg ipamorelin, subcutaneous, fasted
  • Evening: 1–2 mg tesamorelin, subcutaneous, before bed

This stack produces synergistic GH output by hitting both the GHRH pathway (tesamorelin) and the ghrelin pathway (ipamorelin) simultaneously [3][4][9]. Ipamorelin is the preferred ghrelin mimetic here because it does not raise prolactin or cortisol, two hormones you want controlled during a body composition protocol [1].

Greg Doucette has noted that this combination synergistically increases IGF-1 and can stimulate appetite, which benefits athletes in a gaining phase [11]. For fat loss, the appetite stimulation is typically mild and manageable, especially compared to MK-677 or GHRP-6 [9][19].

Cycling is recommended. Most protocols run 8–12 weeks on, followed by 4 weeks off to prevent pituitary desensitization and maintain natural GH pulsatility [12][15]. Ben Greenfield has used a 5-days-on, 2-days-off schedule within the active cycle for additional receptor recovery [15].

Tesamorelin Dosage for Bodybuilding

Tesamorelin dosage for bodybuilding runs higher than clinical anti-aging doses. A longevity-focused physician might prescribe 1 mg daily. Bodybuilders commonly use 2 mg daily and occasionally push higher when stacking aggressively [23][43].

The bodybuilding application centers on fat loss (particularly stubborn midsection fat), faster recovery between training sessions, and improved sleep quality that supports muscle growth. Tesamorelin addresses all three through elevated GH.

A typical bodybuilding peptide stack might include [43]:

  • Tesamorelin 2 mg nightly
  • Ipamorelin 200–300 mcg morning and pre-bed
  • BPC-157 250–500 mcg for joint and tissue repair
  • SS-31 for mitochondrial support and recovery

During a cut, tesamorelin pairs well with a modest caloric deficit and fasted morning cardio. Elevated GH levels increase fatty acid oxidation during low-insulin states, making fasted training more effective at mobilizing stored body fat.

During a bulk, GH elevation supports nutrient partitioning, shuttling more calories toward muscle tissue and away from fat storage. The intracellular water retention effect creates fuller muscles and better pumps [4].

Monitor your IGF-1 levels throughout any bodybuilding peptide protocol. Target 100–250 ng/mL to balance anabolic benefits against potential risks [8]. Pushing IGF-1 above 300 ng/mL offers diminishing returns and raises concern about long-term effects.

Tesamorelin Dosage for Fat Loss

For dedicated fat loss, tesamorelin dosage for fat loss follows the standard 1–2 mg daily protocol, but the supporting variables shift to maximize lipolysis.

Injection timing: Evening dosing remains optimal. Some users add a second low-dose injection (0.5–1 mg) in the morning on an empty stomach to create an additional fasted GH pulse for morning fat oxidation.

Fasting window: Tesamorelin works best when blood sugar and insulin are low. Inject at least 2 hours after your last meal. Avoid eating for 30–60 minutes post-injection. Insulin blunts GH release, so keeping the injection window clean of carbohydrates is critical.

Stack for fat loss: The ipamorelin-tesamorelin combination produces superior fat-loss results compared to either peptide alone [9]. Early reports suggest outcomes competitive with traditional GH protocols, without the appetite spikes seen with other GHRPs [9]. Adding 5-Amino-1MQ pre-workout can further enhance mitochondrial fat oxidation [5][15].

Realistic expectations: Sustainable fat loss with tesamorelin ranges from 1–2 pounds per week when combined with a moderate caloric deficit and resistance training [52]. Visceral fat reduction is often noticeable within 4–6 weeks as waist circumference decreases before the scale moves much. Because tesamorelin preferentially targets visceral fat, you may lose inches from your waist faster than total body weight suggests.

Tesamorelin Side Effects

Tesamorelin side effects are generally mild at clinical doses, which is one reason it earned FDA approval. But no compound is side-effect-free, and higher bodybuilding doses increase risk.

Common side effects include:

  • Injection site reactions: redness, itching, or mild pain at the injection site. This is the most frequently reported adverse effect and typically resolves within minutes.
  • Joint pain and stiffness: elevated GH can cause transient arthralgia, particularly in the first 2–4 weeks as the body adjusts.
  • Water retention: mild peripheral edema, especially in the hands and feet. Dose-dependent. Usually subsides as the body acclimates.
  • Paresthesia: numbness or tingling in the extremities, another GH-mediated effect that tends to be transient.

Less common but notable:

  • Blood sugar elevation: GH is a counter-regulatory hormone to insulin. At higher doses, tesamorelin can raise fasting glucose and reduce insulin sensitivity [8]. Anyone with pre-diabetes or insulin resistance should monitor blood glucose closely. Combining GHRH analogs with micro-doses of a ghrelin agonist can minimize hyperglycemia risk compared to high-dose monotherapy [8].
  • Hypothalamic-pituitary effects: Pulsatile peptides like tesamorelin may alter hypothalamic gene expression, even with short cycling schedules [19]. This is why cycling on and off is strongly recommended over continuous year-round use.
  • Lipid changes: Some users report shifts in lipid profiles during extended GH elevation. Monitor LDL, HDL, and triglycerides through regular bloodwork.

Compared to exogenous GH injections, tesamorelin carries a lower risk profile because it works through your body’s own regulatory mechanisms rather than overriding them. The pituitary maintains feedback control, a built-in safety brake that injected somatropin lacks [12].

Tesamorelin Injection, Tablets, and Oral Options

Tesamorelin Injection

The standard delivery method is subcutaneous tesamorelin injection, a small insulin-type needle injected into abdominal fat. Technique: pinch a fold of skin, insert the needle at a 45-degree angle, inject slowly, rotate sites to prevent lipodystrophy at the injection point.

The fear is almost always worse than the reality. The needles are tiny (29–31 gauge), and most users report the injection as painless after the first few attempts [3].

Tesamorelin Tablets and Oral Peptides

Tesamorelin tablets and tesamorelin peptide oral formulations come up frequently as injection alternatives. The problem is bioavailability. Peptides are proteins. Your stomach acid and digestive enzymes break them down before they reach systemic circulation. Injectable peptides remain the preferred route for most practitioners [12].

Some compounding pharmacies offer sublingual or oral preparations using absorption-enhancing technologies. These may offer convenience, but the clinical data supporting their efficacy is far thinner than what exists for injectable tesamorelin. If fat loss and body composition are your primary goals, injectable remains the gold standard.

Tesamorelin for Sale: Sourcing Considerations

Where you obtain tesamorelin for sale matters more than most people realize. Black-market peptides carry significant purity and dosing risks [2]. Contamination with lipopolysaccharides can cause inflammation and negate the very benefits you’re after [24]. Source from licensed compounding pharmacies with third-party testing, or obtain a prescription for brand-name Egrifta through your physician.

Frequently Asked Questions

What Is Tesamorelin?

Tesamorelin is a synthetic growth hormone-releasing hormone analog, a 44-amino acid peptide that stimulates your pituitary gland to produce and secrete more growth hormone naturally. It is the active ingredient in Egrifta, an FDA-approved medication for reducing excess abdominal fat in HIV-positive patients with lipodystrophy [1][2].

What Does Tesamorelin Do?

Tesamorelin increases endogenous growth hormone production, which elevates IGF-1 levels and activates lipolysis, particularly in visceral fat deposits. It reduces abdominal fat, improves body composition, supports deeper sleep, and may enhance recovery from exercise [3][4][22]. Unlike exogenous GH, it preserves your body’s natural feedback mechanisms [12].

Is Tesamorelin FDA-Approved?

Yes. Tesamorelin (brand name Egrifta) is FDA-approved for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy [1][2][8]. It is one of very few peptides with full regulatory approval, which speaks to both its efficacy and safety profile. Off-label use for general body composition improvement is common in anti-aging and sports medicine clinics.

Is Tesamorelin Safe?

At clinical doses of 1–2 mg daily, tesamorelin has a well-established safety record based on the trials that led to FDA approval. Common side effects (injection site reactions, mild water retention, joint stiffness) are typically transient and manageable. The primary concerns with long-term use involve blood sugar elevation and potential hypothalamic-pituitary axis changes [8][19]. Cycling protocols (8–12 weeks on, 4 weeks off) mitigate these risks. Always use under physician guidance with regular bloodwork monitoring.

What Is Tesamorelin Used For?

Officially, tesamorelin is prescribed for HIV-associated lipodystrophy. In practice, it is widely used off-label for visceral fat reduction, body composition optimization, anti-aging protocols, improved sleep quality, and enhanced recovery in athletes [1][5][6]. It is commonly stacked with ipamorelin for synergistic GH release [3][4][9].

References

  1. Mind Pump TV - Specific FDA-approved peptides: TA-1, Tesamorelin, Ipamorelin (https://www.youtube.com/watch?v=HT57yASowpI)
  2. Thomas DeLauer - Peptides as Prescription Medications (https://www.youtube.com/watch?v=sR4J7GpJeG0)
  3. Ben Greenfield - Peptide Stacks for Muscle Gain and Fat Loss (https://www.youtube.com/watch?v=B1Eu5YGJsTQ)
  4. Ben Greenfield - Ipa-Tesamorelin Stack for Muscle & Fat Effects (https://www.youtube.com/watch?v=j9oZL05aoo0)
  5. Thomas DeLauer - Other Fat Loss and Muscle Peptides (https://www.youtube.com/watch?v=baqWMuX5YfI)
  6. Ben Greenfield - Growth-Hormone Peptide Stack (https://www.youtube.com/watch?v=vGFY2Ba_EOk)
  7. High Intensity Health - Peptides Require Lifestyle Foundations (https://www.youtube.com/watch?v=SsFndSNVXIk)
  8. Thomas DeLauer - GHRH Analogs & Dosing (https://www.youtube.com/watch?v=OQTsicKIajE)
  9. More Plates More Dates - Ipamorelin + Tesamorelin Peptide Stack for Fat Loss (https://www.youtube.com/watch?v=riDoapSVb3g)
  10. Greg Doucette - Peptide protocols: BPC-157, Tesamorelin/Ipamorelin, IGF-1 LR3 (https://www.youtube.com/watch?v=VnzNaVHdW-g)
  11. High Intensity Health - Peptide Strategies to Raise Growth Hormone & IGF-1 (https://www.youtube.com/watch?v=z9aLNGNbhDQ)
  12. Vigorous Steve - Peptide GH Secretagogues Overview (https://www.youtube.com/watch?v=Rrn5tkATgXw)
  13. Thomas DeLauer - GHRPs and GHRHs for Growth Hormone Stimulation (https://www.youtube.com/watch?v=804mwP1mx8w)
  14. Ben Greenfield - Peptide muscle-building protocol (https://www.youtube.com/watch?v=0tRv3oyfj34)
  15. More Plates More Dates - Ghrelin-agonist peptides stress response and PSA spikes (https://www.youtube.com/watch?v=QJ1VPchw3ns)
  16. Thomas DeLauer - Tesamorelin’s Impact on Visceral Fat (https://www.youtube.com/watch?v=1wnCq2wGjkU)
  17. Ryan Russo - Dosage Ranges and Common Side Effects (https://www.youtube.com/watch?v=buSIuGUkjkQ)
  18. More Plates More Dates - Peptides and Growth Hormone (https://www.youtube.com/watch?v=98EV0vhDYj8)
  19. High Intensity Health - Ozempic and Semaglutide’s Limited Fat Loss and Muscle Loss (https://www.youtube.com/watch?v=iKsNx2vbcQs)
  20. Blackburn GL, Waltman BA - Pharmacotherapy to reduce visceral fat (https://pubmed.ncbi.nlm.nih.gov/16473261/)
  21. Mind Pump TV - Peptide Protocols for Bulking and Cutting Phases (https://www.youtube.com/watch?v=Mp46ytwZlCA)
  22. Thomas DeLauer - Safe Weekly & Monthly Targets (https://www.youtube.com/watch?v=ywLdDF5H9Qk)
  23. Vigorous Steve - Sleep Optimization & Peptide Enhancement (https://www.youtube.com/watch?v=XT6XFvYYsEY)
  24. Dr. Gabrielle Lyon - Peptide categories and real-world BPC-157 results (https://www.youtube.com/watch?v=N0Fe_PYJzm4)

Cart

🎄 SPECIAL ACCESS: EXPIRES SOON!

Join thousands getting stronger this X-mas!

START YOUR NEW YEAR'S RESOLUTION